Literature DB >> 364211

[Fixed lupus erythematosus (its treatment with thalidomide)].

J Barba Rubio, F Franco González.   

Abstract

The results obtained from the first 20 cases of Discoid Lupus Erithematosus treated with Thalidomide showed evidence of its great efficacy, evident from the first 15 days of treatment. In the incipient cases the results were even spectacular. 2. The minimum dosage used by the authors seems to be adequate on the basis of the results obtained. 3. The precise mode of action of thalidomide but it is thought that in acts on the hypothalamus. 4. The intolerance to Thalidomide and its undesireable side effects consisted slight somnolence; only one case had fever, cephalea, arthralgia, vertigo, nausea and urticaria which is unknown made it necessary to discontinue the medication. 5. The teratogenic effect of thalidomide obliges us to redouble the vigilance in women in age of reproduction by using of parenteral contraceptives applied by or in presence of the investigator. This study included one case that started treatment during the 7th month of pregnancy, without any problem and with an excellent result. The patient gave birth to a healthy full term infant. 6. It is recognized that this preliminary study should be continued with a greater number of cases and that these should be continued for a longer follow-up evaluation. At the present time, the authors believe that thalidomide is the best treatment for Discoid Lupus Erythematosus.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 364211

Source DB:  PubMed          Journal:  Med Cutan Ibero Lat Am        ISSN: 0210-5187


  3 in total

Review 1.  Thalidomide in human immunodeficiency virus (HIV) patients. A review of safety considerations.

Authors:  V Günzler
Journal:  Drug Saf       Date:  1992 Mar-Apr       Impact factor: 5.606

2.  Thalidomide in dermatology: revisited.

Authors:  Iffat Hassan; Konchok Dorjay; Parvaiz Anwar
Journal:  Indian J Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.494

3.  Thalidomide treatment in cutaneous lesions of systemic lupus erythematosus: a multicenter study in China.

Authors:  Dandan Wang; Haifeng Chen; Shiying Wang; Yaohong Zou; Jing Li; Jieping Pan; Xiangdang Wang; Tianli Ren; Yu Zhang; Zhiwei Chen; Xuebing Feng; Lingyun Sun
Journal:  Clin Rheumatol       Date:  2016-04-21       Impact factor: 3.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.